Literature DB >> 22327777

Analytical variables influencing the HCV RNA determination by TaqMan real-time PCR in routine clinical laboratory practice.

Abida Raza1, Zameer Ali, Javaid Irfan, Shahnaz Murtaza, Samina Shakeel.   

Abstract

Hepatitis C virus (HCV) quantification is used as a prognostic marker for treatment success. In a routine clinical laboratory some infinitesimal sample handling factors can contribute to variability and loss of precision in HCV quantification. This may include blood collection tubes, blood drawing procedure, sample processing and storage temperatures. In current study blood was collected in tubes with different anticoagulant type (spray vs. liquid), group 1, blood was drawn with possible suck of methylated spirit through needle (experimental group) while avoiding the methylated spirit suck (control group) group 2, plasma separation was delayed from 0 to 60 min for group 3, plasma storage at different temperatures group 4. All samples were analyzed using Corbett research real time PCR system using AJ Roboscreen Kit. Mean viral load difference between spray vs. liquid was found 3.6 × 10(5) IU/ml (p < 0.001). Methylated spirit inhibited the viral load quantification with a value of 4.8 × 10(5) IU/ml (p < 0.001). Mean viral load difference was found 1.2 × 10(5) IU/ml (p < 0.05). Delay in centrifugation from 0 to 60 min and plasma placement at 25 °C for 15 min before freezing had no effect (p = 0.5996). Plasma storage temperature at -80 and -20 °C did not affect significantly on RNA levels (p > 0.05). In conclusion blood collection tubes and procedures can be a key factor in variability of results, that might affect the treatment response decision.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22327777     DOI: 10.1007/s11033-012-1574-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  31 in total

Review 1.  Hepatitis C. Development of new drugs and clinical trials: promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27-March 1, 2003.

Authors:  Jean-Michel Pawlotsky; John G McHutchison
Journal:  Hepatology       Date:  2004-02       Impact factor: 17.425

2.  Hepatitis C virus RNA quantitation and degradation studies in whole blood samples in vitro.

Authors:  J Watson; S Graves; J Ferguson; C D'Este; R Batey
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

3.  Effects of storage and type of blood collection tubes on hepatitis C virus level in whole blood samples.

Authors:  H H Kessler; E Stelzl; R B Raggam; J Haas; F Kirchmeir; K Hegenbarth; E Daghofer; B I Santner; E Marth; R E Stauber
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Multicenter trials need to use the same assay for hepatitis C virus viral load determination.

Authors:  Syria Laperche; Françoise Bouchardeau; Vincent Thibault; Bruno Pozzetto; Sophie Vallet; Arielle R Rosenberg; Anne-Marie Roque-Afonso; Michèle Gassin; Françoise Stoll-Keller; Pascale Trimoulet; Elyanne Gault; Bruno Chanzy; Bernard Mercier; Michel Branger; Jean-Michel Pawlotsky; Cécile Henquell; Françoise Lunel; Catherine Gaudy-Graffin; Sophie Alain; Marie-Laure Chaix; Gilles Duverlie; Jacques Izopet; Jean-Jacques Lefrère
Journal:  J Clin Microbiol       Date:  2007-10-03       Impact factor: 5.948

Review 5.  Measuring hepatitis C viremia in clinical samples: can we trust the assays?

Authors:  J M Pawlotsky
Journal:  Hepatology       Date:  1997-07       Impact factor: 17.425

6.  Evaluation of effect of specimen-handling parameters for plasma preparation tubes on viral load measurements obtained by using the Abbott RealTime HIV-1 load assay.

Authors:  Helen Fernandes; Svetlana Morosyuk; Klara Abravaya; Madhuri Ramanathan; Lynne Rainen
Journal:  J Clin Microbiol       Date:  2010-05-19       Impact factor: 5.948

7.  Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus.

Authors:  Samantha Blackham; Andrew Baillie; Fadel Al-Hababi; Katja Remlinger; Shihyun You; Robert Hamatake; Michael J McGarvey
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

8.  Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus.

Authors:  H T Cuypers; D Bresters; I N Winkel; H W Reesink; A J Weiner; M Houghton; C L van der Poel; P N Lelie
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

9.  Quantitation of hepatitis C virus using an in-house real-time reverse transcriptase polymerase chain reaction in plasma samples.

Authors:  Hubert Darius J Daniel; Paul R Grant; Jeremy A Garson; Richard S Tedder; George M Chandy; Priya Abraham
Journal:  Diagn Microbiol Infect Dis       Date:  2008-05-16       Impact factor: 2.803

10.  Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays.

Authors:  F Lunel; P Cresta; D Vitour; C Payan; B Dumont; L Frangeul; D Reboul; C Brault; J C Piette; J M Huraux
Journal:  Hepatology       Date:  1999-02       Impact factor: 17.425

View more
  2 in total

1.  The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract.

Authors:  I M Modlin; M Kidd; L Bodei; I Drozdov; H Aslanian
Journal:  Am J Gastroenterol       Date:  2015-06-02       Impact factor: 10.864

2.  Utility of a ready-to-use PCR system for neuroendocrine tumor diagnosis.

Authors:  Mark Kidd; Ignat A Drozdov; Somer Matar; Nicole Gurunlian; Nicholas J Ferranti; Anna Malczewska; Philip Bennett; Lisa Bodei; Irvin M Modlin
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.